Time filter

Source Type

Patent
Golden Biotechnology Corporation | Date: 2015-08-18

The present invention is directed to therapeutic methods for treating benign prostatic hyperplasia (BPH) in a subject comprising administering an effective amount of a herbal mixture, and an anti-BPH agent to said subject where said herbal mixture comprises Astragalus membranaceus and Glycine max; and compositions thereof.


Patent
Golden Biotechnology Corporation | Date: 2017-03-01

The present invention is directed to therapeutic methods for treating benign prostatic hyperplasia (BPH) in a subject comprising administering an effective amount of a herbal mixture, and an anti-BPH agent to said subject where said herbal mixture comprises Astragalus membranaceus and Glycine max; and compositions thereof.


Patent
Golden Biotechnology Corporation | Date: 2014-03-13

The present invention is directed to therapeutic methods and compositions involving cyclohexenone compounds where said compounds inhibit farnesyltransferase or Ras. The therapeutic methods (e.g. for treating cancers) comprise contacting a tumor with a cyclohexenone compound and an anticancer agent.


Patent
Golden Biotechnology Corporation | Date: 2014-02-20

Provided herein are processes of preparing cyclohexenone compounds useful for cancer treatments and/or diseases.


Patent
Golden Biotechnology Corporation | Date: 2014-02-20

The present invention provides methods and compositions for treating leukemia by cyclohexenone compounds.


Patent
Golden Biotechnology Corporation | Date: 2016-05-09

Provided herein are processes of preparing cyclohexenone compounds useful for cancer treatments and/or diseases.


Patent
Golden Biotechnology Corporation | Date: 2016-02-17

Provided herein are compositions and processes of making of anticancer compounds useful for cancer treatments. These cyclohexenone compounds show an unexpected result against certain cancer cells compared to their known analogs.


The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of bladder cancer cells and be used as a pharmaceutical composition to inhibit the bladder tumor growth.


Patent
Golden Biotechnology Corporation | Date: 2014-03-03

The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3 -dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6, 10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of lymphoma cells and be used as a pharmaceutical composition to inhibit the lymphoma tumor growth.


Patent
Golden Biotechnology Corporation | Date: 2016-03-02

The present invention provides methods for treating glomerulosclerosis such as focal segmental glomerulosclerosis (FSGS) or glomerulonephritis such as immunoglobulin A nephropathy (IgAN) by cyclohexenone compounds.

Loading Golden Biotechnology Corporation collaborators
Loading Golden Biotechnology Corporation collaborators